Pulmonx Corp. (LUNG), a commercial-stage medical technology company, is scheduled to report financial results for the second quarter ended June 30, 2024, after the close of trading on July 31.
The company is a provider of minimally invasive treatments for chronic obstructive pulmonary disease, and its marketed products include the Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.